Centre Hospitalier de Mont-de-Marsan

corporate_fareorganization

Centre Hospitalier de Mont-de-Marsan

- Funding / Projects
  (3)

3 Projects, page 1 of 1

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
assignment_turned_inProjectPartners:Centre François Baclesse, Institut Curie, Centre Eugène Marquis, Centre René Gauducheau, Institut Paoli-Calmettes- (IPC) +10 partners
Centre François Baclesse,
Institut Curie,
Centre Eugène Marquis,
Centre René Gauducheau,
Institut Paoli-Calmettes- (IPC),
Centre Hospitalier de Mont-de-Marsan,
Centre Antoine Lacassagne,
Clinique Sainte Marguerite,
Centre Léon Bérard,
Hôpital Saint-Louis,
Institut Jean Godinot,
Hôpital Saint Joseph,
Hôpital Édouard Herriot,
Institut Gustave Roussy,
Institut de Cancérologie de l'Ouest
Funder: Institut National du Cancer Project Code: INCa-DGOS-7193
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
NEOPAN Randomised trial of chemotherapy with Folfirinox or gemcitabine followed by radiochemotherapy in locally advanced pancreatic carcinoma
assignment_turned_inProjectPartners:Centre Antoine Lacassagne, Institut de Cancérologie de Lorraine, Hôpital de La Source, Institut Bergonié, Centre Hospitalier Universitaire d'Angers +15 partners
Centre Antoine Lacassagne,
Institut de Cancérologie de Lorraine,
Hôpital de La Source,
Institut Bergonié,
Centre Hospitalier Universitaire d'Angers,
Hôpital Robert Debré,
Hôpital Claude Huriez,
Centre Oscar Lambret,
Centre Hospitalier de Mont-de-Marsan,
CHU Dijon-Bourgogne - Centre Hospitalier Universitaire de Dijon,
Groupe Hospitalier Pitié Salpétrière,
Hôpital Jean Minjoz,
Centre René Gauducheau,
Centre Eugène Marquis,
Hôpital Charles-Nicolle,
Hôpital Avicenne,
Hôpital René Huguenin - Institut Curie,
Institut Gustave Roussy,
Centre Henri Becquerel,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-5571
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
VEFORA.- Randomized multicenter phase II/III study evaluating efficacy and tolerance (composite criterion) of chemotherapy with fractionated cisplatine/gemcitabine or carboplatine/gemcitabine in advanced or metastatic urothelial cancer patients with impaired renal function (creatinine clearance between 40 and 60 ml/min according to Cockroft and Gault).
assignment_turned_inProjectPartners:Institut Gustave Roussy, Centre François Baclesse, Institut Bergonié, CHV, Centre Léon Bérard +10 partners
Institut Gustave Roussy,
Centre François Baclesse,
Institut Bergonié,
CHV,
Centre Léon Bérard,
Institut de Cancérologie de l'Ouest,
Centre Hospitalier de Mont-de-Marsan,
Hôpital Saint-Louis,
Centre Georges-François Leclerc,
Institut de cancérologie Lucien Neuwirth,
Centre Hospitalier Universitaire de Nîmes,
Hôpital Jean Minjoz,
Centre René Gauducheau,
Institut Claudius Regaud,
ICM-VAL D'AURELLE
Funder: Institut National du Cancer Project Code: INCa-DGOS-5424
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Centre Hospitalier de Mont-de-Marsan

Centre Hospitalier de Mont-de-Marsan

3 Projects, page 1 of 1

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.

NEOPAN Randomised trial of chemotherapy with Folfirinox or gemcitabine followed by radiochemotherapy in locally advanced pancreatic carcinoma

Loading